Indication
Acute Coronary Syndromes
2 clinical trials
3 products
Clinical trial
Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary SyndromesStatus: Completed, Estimated PCD: 2023-01-25
Product
Interleukin-2Clinical trial
The Low-Dose Interleukin-2 For The Reduction Of Vascular Inflammation In Acute Coronary Syndromes -Clinical Outcomes And Follow-up StudyStatus: Recruiting, Estimated PCD: 2027-04-30
Product
AldesleukinProduct
Dextrose 5%